A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma

Locally advanced or metastatic urothelial cancer is an aggressive form of cancer with high recurrence rates and low survival. Nectin-4 is a cell adhesion molecule commonly expressed in several tumors, including high expression in urothelial cancer. Enfortumab vedotin is an antibody–drug conjugate co...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Invest New Drugs
Main Authors: Takahashi, Shunji, Uemura, Motohide, Kimura, Tomokazu, Kawasaki, Yoshihide, Takamoto, Atsushi, Yamaguchi, Akito, Melhem-Bertrandt, Amal, Gartner, Elaina M., Inoue, Takashi, Akazawa, Rio, Kadokura, Takeshi, Tanikawa, Toshiki
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2019
Teme:
Phase I Studies
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340645/
https://ncbi.nlm.nih.gov/pubmed/31444589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-019-00844-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki